Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hochhaus

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Journal of Pharmacokinetics and Biopharmaceutics|November 24, 1999
A pharmacokinetic/pharmacodynamic approach to predict the cumulative cortisol suppression of inhaled corticosteroidsB Meibohm, G Hochhaus, H Möllmann, et al.
Pharmaceutical Research|November 1, 1996
Pulmonary targeting of liposomal triamcinolone acetonide phosphateR J Gonzalez-Rothi, S Suarez, G Hochhaus, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 1, 1996
Pharmacokinetics and pharmacodynamics of cloprednolH Möllmann, G Hochhaus, S Rohatagi, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 4, 1999
Mechanism-based PK/PD model for the lymphocytopenia induced by endogenous and exogenous corticosteroidsB Meibohm, H Derendorf, H Möllmann, et al.
Journal of Clinical Pharmacology|August 1, 1997
Dependency of cortisol suppression on the administration time of inhaled corticosteroidsB Meibohm, G Hochhaus, S Rohatagi, et al.
AAPS Pharmsci|June 7, 2002
Receptor binding studies of soft anticholinergic agentsF Huang, P Buchwald, C E Browne, et al.
European Journal of Clinical Pharmacology|April 29, 1998
Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administrationH Möllmann, M Wagner, B Meibohm, et al.
Journal of Clinical Pharmacology|March 20, 1998
Pharmacokinetic/pharmacodynamic evaluation of systemic effects of flunisolide after inhalationH Möllmann, H Derendorf, J Barth, et al.
Clinical Pharmacology and Therapeutics|August 8, 1998
Pharmacokinetics of intravenous dynorphin A(1-13) in opioid-naive and opioid-treated human volunteersP L Gambús, T W Schnider, C F Minto, et al.
Die Pharmazie|July 10, 2010
Feasibility of localized immunosuppression: 1. Exploratory studies with glucocorticoids in a biohybrid device designed for cell transplantationP Buchwald, N Bocca, S Marzorati, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Journal of Pharmacokinetics and Biopharmaceutics|November 24, 1999
A pharmacokinetic/pharmacodynamic approach to predict the cumulative cortisol suppression of inhaled corticosteroidsB Meibohm, G Hochhaus, H Möllmann, et al.
Pharmaceutical Research|November 1, 1996
Pulmonary targeting of liposomal triamcinolone acetonide phosphateR J Gonzalez-Rothi, S Suarez, G Hochhaus, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 1, 1996
Pharmacokinetics and pharmacodynamics of cloprednolH Möllmann, G Hochhaus, S Rohatagi, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 4, 1999
Mechanism-based PK/PD model for the lymphocytopenia induced by endogenous and exogenous corticosteroidsB Meibohm, H Derendorf, H Möllmann, et al.
Journal of Clinical Pharmacology|August 1, 1997
Dependency of cortisol suppression on the administration time of inhaled corticosteroidsB Meibohm, G Hochhaus, S Rohatagi, et al.
AAPS Pharmsci|June 7, 2002
Receptor binding studies of soft anticholinergic agentsF Huang, P Buchwald, C E Browne, et al.
European Journal of Clinical Pharmacology|April 29, 1998
Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administrationH Möllmann, M Wagner, B Meibohm, et al.
Journal of Clinical Pharmacology|March 20, 1998
Pharmacokinetic/pharmacodynamic evaluation of systemic effects of flunisolide after inhalationH Möllmann, H Derendorf, J Barth, et al.
Clinical Pharmacology and Therapeutics|August 8, 1998
Pharmacokinetics of intravenous dynorphin A(1-13) in opioid-naive and opioid-treated human volunteersP L Gambús, T W Schnider, C F Minto, et al.
Die Pharmazie|July 10, 2010
Feasibility of localized immunosuppression: 1. Exploratory studies with glucocorticoids in a biohybrid device designed for cell transplantationP Buchwald, N Bocca, S Marzorati, et al.
Pageof 9